Reuters logo
BRIEF-Astrazeneca says U.S. FDA approves Faslodex
2017年8月28日 / 上午11点08分 / 3 个月前

BRIEF-Astrazeneca says U.S. FDA approves Faslodex

Aug 28 (Reuters) - Astrazeneca Plc:

* FASLODEX® (FULVESTRANT) RECEIVES US FDA APPROVAL AS MONOTHERAPY FOR EXPANDED USE IN HR+, HER2- ADVANCED BREAST CANCER

* FDA APPROVAL IS BASED ON PIVOTAL DATA FROM PHASE III FALCON TRIAL Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below